This is the authors' abstract. We don't add key points for this paper.
Overall, implementation of this targeted lymphoid NGS panel as part of regular hematopathology practice was found to be a beneficial adjunct in the evaluation of low-grade LPDs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jajosky et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: